Search Results - "Alegria, Guillermo Carvajal"
-
1
The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle
Published in Autoimmunity reviews (01-11-2020)“…Polymyalgia rheumatica (PMR) is a frequent rheumatic condition among people over 50 years of age. Despite its frequent association with giant cell arteritis…”
Get full text
Journal Article -
2
Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
Published in Frontiers in immunology (15-06-2023)“…Research into giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) has become more important in the last few decades. Physicians are facing several…”
Get full text
Journal Article -
3
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2022)“…Objective Patients at high risk of rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) would benefit from being identified before the onset of…”
Get full text
Journal Article -
4
Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy
Published in Rheumatology and therapy. (01-10-2024)“…Introduction The therapeutic arsenal for psoriatic arthritis (PsA) is gradually being expanded, but the use of these targeted treatments must be optimal. Our…”
Get full text
Journal Article -
5
Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
Published in Rheumatic & musculoskeletal diseases open (01-01-2016)“…ObjectivesNeurological manifestations seem common in primary Sjögren's syndrome (pSS) but their reported prevalences vary. We investigated the prevalence and…”
Get full text
Journal Article -
6
Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren’s disease
Published in Rheumatic & musculoskeletal diseases open (02-10-2024)“…ObjectivesTo develop and validate a web-based ecological momentary assessment (EMA) tool to enhance symptoms monitoring among patients with Sjögren’s disease…”
Get full text
Journal Article -
7
New onset of rheumatoid vasculitis during abatacept therapy and subsequent improvement after rituximab
Published in Joint, bone, spine : revue du rhumatisme (01-10-2016)Get full text
Journal Article -
8
The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials
Published in Autoimmunity reviews (01-07-2024)“…The objective of this systematic review was to provide an overview of current developments and potentially available therapeutic options for polymyalgia…”
Get full text
Journal Article -
9
Efficacy of Janus kinase inhibitors in rheumatoid arthritis
Published in Inflammation research (01-05-2023)“…Background Janus kinase inhibitors (JAKis) is a new therapeutic class in autoimmune and inflammatory diseases. Four molecules are approved in rheumatoid…”
Get full text
Journal Article -
10
Fibroblasts, a target for imaging and therapeutics in rheumatoid arthritis
Published in Rheumatology (Oxford, England) (06-07-2022)Get full text
Journal Article -
11
Against the dryness—an innovative 3D acini model to test new drugs in primary Sjögren’s syndrome
Published in Rheumatology (01-04-2020)Get full text
Journal Article -
12
Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years’ follow-up (ESPOIR Cohort)
Published in Rheumatology (01-08-2023)“…Abstract Objectives Anterior atlanto-axial subluxation (AAS), defined as an anterior atlanto-dental interval ≥3 mm, can occur in RA and carries a risk of…”
Get full text
Journal Article -
13
Abatacept Promotes Regulatory B Cell Functions, Enhancing Their Ability to Reduce the Th1 Response in Rheumatoid Arthritis Patients through the Production of IL-10 and TGF-β
Published in The Journal of immunology (1950) (15-07-2021)“…Abatacept mimics natural CD152 and competes with CD28 for binding to CD80/CD86 on APC, such as B cells, thereby preventing T cell activation. However, its…”
Get full text
Journal Article -
14
Is Tocilizumab as efficient as steroids early in polymyalgia rheumatica?
Published in Seminars in arthritis and rheumatism (01-08-2020)Get full text
Journal Article -
15
Hip Pain Associated with Acetabular Dysplasia in Patients with Suspected Axial Spondyloarthritis: DESIR Cohort Data
Published in BMC musculoskeletal disorders (05-07-2022)“…Objectives To determine whether acetabular dysplasia is associated with hip pain at physical examination among adults with recent-onset inflammatory back pain…”
Get full text
Journal Article -
16
Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica
Published in Rheumatology (01-08-2017)“…The aim was to study lymphocyte subsets and circulating cytokines at diagnosis of PMR and after tocilizumab monotherapy. Eighteen untreated patients with PMR…”
Get full text
Journal Article -
17
Tocilizumab controls bone turnover in early polymyalgia rheumatica
Published in Joint, bone, spine : revue du rhumatisme (01-05-2021)“…•Bone turnover is impaired in polymyalgia rheumatica with an increased resorption.•Tocilizumab restores bone turnover in polymyalgia rheumatica.•Increase of…”
Get full text
Journal Article -
18
Aortic involvement in giant cell arteritis
Published in Joint, bone, spine : revue du rhumatisme (01-03-2021)Get full text
Journal Article -
19
Association of lumbosacral transitional vertebra and sacroiliitis in patients with inflammatory back pain suggesting axial spondyloarthritis
Published in Rheumatology (Oxford, England) (01-07-2020)“…Abstract Objective Lumbosacral transitional vertebras (LSTVs) are common in the general population, but their potential impact on the sacroiliac joints is…”
Get full text
Journal Article -
20
Healthy Patients Are Not the Best Controls for Microbiome-Based Clinical Studies: Example of Sjögren's Syndrome in a Systematic Review
Published in Frontiers in immunology (29-07-2021)“…It has been hypothesized that gut and oral dysbiosis may contribute to the development of primary Sjögren's syndrome (pSS). The aim of this systematic review…”
Get full text
Journal Article